Company / EPS (Basic)
Ovid Therapeutics Inc. EPS (Basic) History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.77
FY2023
5-year range
-$0.77 / $1.78
FY2022-FY2023
Trend
-143.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-0.77 in FY2023.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, eps (basic) decreased 143.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$0.77 | -143.3% |
| FY2022 | $1.78 | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026